STX Tag

Shield Therapeutics PLC – Final Results

Shield Therapeutics plc (LSE:STX), a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, announces its preliminary Group results for the year ended 31 December 2018....

Read More